Monopar Therapeutics MNPR Long-term investments
Long-term investments at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Investments.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's long-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monopar Therapeutics's long-term investments?
- Monopar Therapeutics (MNPR) reported long-term investments of $84.95M in Q1 2026.
- How has Monopar Therapeutics's long-term investments changed year-over-year?
- Monopar Therapeutics's long-term investments increased by 472.4% year-over-year, from $14.84M to $84.95M.
- What does long-term investments mean?
- Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.